Stocks › AMGN

AMGEN INC

AMGN·Nasdaq·United States United States·USD
$435.64
-3.18 (-0.72%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
AMGN
AMGEN INC · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
AMGNS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of AMGN by members of U.S. Congress · 251 on record · 34 in the last 12 months
All congressional trades →
PoliticianStockTypeFiledTraded
David J. TaylorDavid J. TaylorHouse · R · OH AMGNAMGEN INC · Stock Sale
$1,001 - $15,000
Nov 12, 2026 Nov 3, 2026 Filing ↗
David J. TaylorDavid J. TaylorHouse · R · OH AMGNAMGEN INC · Stock Sale
$1,001 - $15,000
Nov 12, 2026 Nov 3, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA AMGNAMGEN INC · Common Stock Sale
$1,001 - $15,000
Nov 5, 2026 Oct 7, 2026 Filing ↗
Sheldon WhitehouseSheldon WhitehouseSenate · D · RI AMGNAMGEN INC · Stock Sale
$15,001 - $50,000
Nov 2, 2026 Oct 15, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA AMGNAMGEN INC · Common Stock Purchase
$1,001 - $15,000
Oct 8, 2026 Sep 4, 2026 Filing ↗
David J. TaylorDavid J. TaylorHouse · R · OH AMGNAMGEN INC · Stock Purchase
$1,001 - $15,000
Oct 1, 2026 Sep 22, 2026 Filing ↗
David J. TaylorDavid J. TaylorHouse · R · OH AMGNAMGEN INC · Stock Sale
$1,001 - $15,000
Sep 5, 2026 Aug 26, 2026 Filing ↗
David J. TaylorDavid J. TaylorHouse · R · OH AMGNAMGEN INC · Stock Sale
$1,001 - $15,000
Sep 5, 2026 Aug 26, 2026 Filing ↗
Sheldon WhitehouseSheldon WhitehouseSenate · D · RI AMGNAMGEN INC · Stock Sale
$1,001 - $15,000
Sep 2, 2026 Aug 12, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA AMGNAMGEN INC · Stock Purchase
$1,001 - $15,000
Aug 8, 2026 Jul 8, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA AMGNAMGEN INC · Common Stock Sale
$1,001 - $15,000
Aug 8, 2026 Jul 20, 2026 Filing ↗
Tommy TubervilleTommy TubervilleSenate · R · AL AMGNAMGEN INC · Stock Sale
$15,001 - $50,000
Aug 5, 2026 Apr 15, 2025 Filing ↗
Alan ArmstrongAlan ArmstrongSenate · R · OK AMGNAMGEN INC · Stock Sale
$15,001 - $50,000
Jul 21, 2026 Mar 27, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA AMGNAMGEN INC · Common Stock Purchase
$1,001 - $15,000
Jul 7, 2026 Jun 30, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA AMGNAMGEN INC · Common Stock Purchase
$1,001 - $15,000
Jul 7, 2026 Jun 2, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA AMGNAMGEN INC · Stock Purchase
$1,001 - $15,000
Jul 7, 2026 Jun 16, 2026 Filing ↗
David J. TaylorDavid J. TaylorHouse · R · OH AMGNAMGEN INC · Stock Purchase
$1,001 - $15,000
Jun 12, 2026 Jun 5, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA AMGNAMGEN INC · Stock Purchase
$15,001 - $50,000
Jun 10, 2026 May 1, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA AMGNAMGEN INC · Common Stock Sale
$15,001 - $50,000
Jun 10, 2026 May 15, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA AMGNAMGEN INC · Stock Purchase
$15,001 - $50,000
Jun 10, 2026 May 27, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA AMGNAMGEN INC · Stock Sale
$15,001 - $50,000
May 11, 2026 Apr 24, 2026 Filing ↗
Maria Elvira SalazarMaria Elvira SalazarHouse · R · FL AMGNAMGEN INC · Stock Sale
$15,001 - $50,000
May 8, 2026 Apr 17, 2026 Filing ↗
Maria Elvira SalazarMaria Elvira SalazarHouse · R · FL AMGNAMGEN INC · Stock Purchase
$15,001 - $50,000
Apr 21, 2026 Mar 24, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA AMGNAMGEN INC · Common Stock Sale
$15,001 - $50,000
Apr 7, 2026 Mar 30, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA AMGNAMGEN INC · Common Stock Purchase
$15,001 - $50,000
Mar 9, 2026 Feb 24, 2026 Filing ↗

Whale Activity

Position changes in AMGN reported for 2026-09-30 by 3377 institutional filers
Increased: 1211New: 232Held: 478Decreased: 1224Closed: 98No prior filing: 134
  • Increased1211
  • New232
  • Held478
  • Decreased1224
  • Closed98
  • No prior filing134
FilerSharesValueChange
BlackRock, Inc.48.9M$20.62Bdecreased
VANGUARD CAPITAL MANAGEMENT LLC35.4M$14.92Bincreased
STATE STREET CORP31.0M$13.05Bincreased
Capital World Investors27.1M$11.43Bdecreased
Invesco Ltd.16.6M$6.98Bincreased
GEODE CAPITAL MANAGEMENT, LLC16.0M$6.74Bincreased
VANGUARD PORTFOLIO MANAGEMENT LLC15.1M$6.35Bincreased
CHARLES SCHWAB INVESTMENT MANAGEMENT INC14.0M$5.89Bdecreased
MORGAN STANLEY13.6M$5.71Bdecreased
WELLS FARGO & COMPANY/MN6.9M$2.92Bdecreased
JPMORGAN CHASE & CO6.8M$2.88Bincreased
NORTHERN TRUST CORP6.1M$2.55Bdecreased

Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.

Insider Trading

Net shares bought (+) or sold (−) on the open market by AMGN insiders, by quarter · Form 4
-100.0K-50.0K050.0K100.0K2025 Q1: -80.1K2025 Q12025 Q2: -2,5002025 Q22025 Q3: -1,2672025 Q32025 Q4: -10.9K2025 Q42026 Q1: -55.8K2026 Q12026 Q2: -1,2372026 Q22026 Q3: -10.1K2026 Q32026 Q4: 02026 Q4

Recent Insider Transactions

2,547 transactions on record · newest first
All insider activity →
InsiderTypeSharesPriceValueDate
Khosla RachnaSVP, Business Development Sale −1,252 $416.43 $521K Aug 13, 2026 Form 4 ↗
Khosla RachnaSVP, Business Development Option exercise +1,252 $162.60 $204K Aug 13, 2026 Form 4 ↗
Khosla RachnaSVP, Business Development Sale −2,000 $412.57 $825K Aug 11, 2026 Form 4 ↗
Busch Matthew C.VP, Finance & CAO Grant / award +730 $0.00 $0 Aug 7, 2026 Form 4 ↗
ISHRAK OMARDirector Grant / award +85 $0.00 $0 Aug 7, 2026 Form 4 ↗
HOLLEY CHARLES MDirector Grant / award +103 $0.00 $0 Aug 7, 2026 Form 4 ↗
Drake Michael VDirector Grant / award +64 $0.00 $0 Aug 7, 2026 Form 4 ↗
Miller DerekSVP, Human Resources Sale −1,821 $402.54 $733K Aug 6, 2026 Form 4 ↗
Miller DerekSVP, Human Resources Option exercise +1,821 $177.46 $323K Aug 6, 2026 Form 4 ↗
Miller DerekSVP, Human Resources Sale −2,069 $402.54 $833K Aug 6, 2026 Form 4 ↗
Miller DerekSVP, Human Resources Option exercise +2,069 $162.60 $336K Aug 6, 2026 Form 4 ↗
Grygiel Nancy A.SVP & CCO Sale −1,000 $402.16 $402K Aug 6, 2026 Form 4 ↗
Grygiel Nancy A.SVP & CCO Option exercise +1,000 $177.31 $177K Aug 6, 2026 Form 4 ↗
Grygiel Nancy A.SVP & CCO Sale −1,970 $402.16 $792K Aug 6, 2026 Form 4 ↗
Grygiel Nancy A.SVP & CCO Option exercise +1,970 $177.46 $350K Aug 6, 2026 Form 4 ↗
MILES AMY EDirector Grant / award +665 $0.00 $0 May 19, 2026 Form 4 ↗
Kullman Ellen JamisonDirector Grant / award +665 $0.00 $0 May 19, 2026 Form 4 ↗
Klotman Mary E.Director Grant / award +665 $0.00 $0 May 19, 2026 Form 4 ↗
Jacks TylerDirector Grant / award +665 $0.00 $0 May 19, 2026 Form 4 ↗
ISHRAK OMARDirector Grant / award +665 $0.00 $0 May 19, 2026 Form 4 ↗

Fund Holders

Mutual funds and ETFs holding AMGN · SEC Form N-PORT
FundSharesValue% of fundAs of
VANGUARD TOTAL STOCK MARKET INDEX FUND
VANGUARD INDEX FUNDS
17.1M$6.20B0.27%Jun 30, 2026
Schwab U.S. Dividend Equity ETF
SCHWAB STRATEGIC TRUST
12.3M$5.28B4.70%Aug 31, 2026
VANGUARD 500 INDEX FUND
VANGUARD INDEX FUNDS
14.0M$5.07B0.30%Jun 30, 2026
Invesco QQQ Trust, Series 111.5M$4.15B0.85%Jun 30, 2026
Fidelity 500 Index Fund
Fidelity Concord Street Trust
7.0M$3.01B0.35%Aug 31, 2026
Income Fund of America7.8M$2.99B2.02%Jul 31, 2026
iShares Core S&P 500 ETF
iShares Trust
7.4M$2.69B0.30%Jun 30, 2026
American Balanced Fund7.1M$2.57B0.89%Jun 30, 2026
State Street(R) SPDR(R) S&P 500(R) ETF Trust6.5M$2.37B0.30%Jun 30, 2026
Washington Mutual Investors Fund6.1M$2.33B1.07%Jul 31, 2026

Mutual funds and ETFs whose N-PORT filings list AMGN's shares (CUSIP 031162100), each fund at its latest report since Apr 22, 2026, largest positions first. Bonds, options and short positions are left out.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings
  • Capital World InvestorsSCHEDULE 13G · passive (13G) · 29.6M shares5.5%
    May 14, 2026 · ↗
  • Vanguard Capital ManagementSCHEDULE 13G · passive (13G) · 40.5M shares7.5%
    Apr 29, 2026 · ↗
  • The Vanguard GroupSCHEDULE 13G/A · passive (13G) · 0 shares0.0%
    Mar 26, 2026 · ↗
  • The Vanguard GroupSCHEDULE 13G/A · passive (13G) · 53.9M shares10.0%
    Sep 8, 2025 · ↗
  • BlackRock, Inc.SCHEDULE 13G/A · passive (13G) · 40.8M shares7.6%
    Apr 17, 2025 · ↗

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming amgen as client
$0$5.0M$10.0M$15.0M$20.0M2023 Q1: $3.7M2023 Q2: $4.7M2023 Q3: $6.0M2023 Q4: $4.4M20232024 Q1: $4.3M2024 Q2: $3.8M2024 Q3: $3.8M2024 Q4: $3.8M20242025 Q1: $4.5M2025 Q2: $6.1M2025 Q3: $4.5M2025 Q4: $4.6M20252026 Q1: $3.5M2026 Q2: $3.4M2026 Q3: $4.1M2026
  • DAN CRIPPENAMGEN · 2026 Q3$15K
    Filing ↗
  • MICHAEL J. LAMOUREUXAMGEN INC. · 2026 Q3 · HCR—
    Filing ↗
  • THE NICKLES GROUP, LLCAMGEN · 2026 Q3 · TAX, TRD, MMM, HCR$60K
    Filing ↗
  • AMGEN, INC.AMGEN INC · 2026 Q3 · MMM, TAX, HCR, CPT$3.1M
    Filing ↗
  • AVENUE SOLUTIONSAMGEN, INC. · 2026 Q3 · MMM$50K
    Filing ↗

Government Contracts

Federal awards to AMGEN INC · USAspending

No federal contract awards found for AMGEN INC.

U.S. Patents

Recent USPTO applications naming AMGEN INC

No USPTO patent applications found for AMGEN INC.

Annual Financials

From AMGN's 10-K filings · XBRL
Fiscal yearFY2025FY2024FY2023FY2022FY2021
Revenue$36.75B$33.42B$28.19B$26.32B$25.98B
Operating income$9.08B$7.26B$7.90B$9.57B$7.64B
Net income$7.71B$4.09B$6.72B$6.55B$5.89B
Diluted EPS$14.23$7.56$12.49$12.11$10.28
Operating cash flow$9.96B$11.49B$8.47B$9.72B$9.26B
Cash and equivalents$9.13B$11.97B$10.94B$7.63B$7.99B
Total assets$90.59B$91.84B$97.15B$65.12B$61.16B
Shareholders' equity$8.66B$5.88B$6.23B$3.66B$6.70B

As AMGEN INC tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Feb 13, 2026 ↗

Stock Splits

Every split and reverse split in the price history
  • 2-for-1Stock splitNov 22, 1999
  • 2-for-1Stock splitMar 1, 1999
  • 2-for-1Stock splitAug 16, 1995
  • 3-for-1Stock splitSep 11, 1991
  • 2-for-1Stock splitAug 13, 1990

Split dates and ratios from the price history · Close Prices from Tiingo.com

Material Events (8-K)

Corporate events filed with the SEC
  • 8-K · Items 2.02, 9.01Results of operationsNov 3, 2026
    EDGAR ↗
  • 8-K · Items 5.02Officer / director changeOct 27, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsAug 4, 2026
    EDGAR ↗
  • 8-K · Items 1.05Jul 31, 2026
    EDGAR ↗
  • 8-K · Items 5.07Shareholder voteMay 20, 2026
    EDGAR ↗
  • 8-K · Items 5.02Officer / director changeMay 19, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsApr 30, 2026
    EDGAR ↗
  • 8-K · Items 5.02, 9.01Officer / director changeApr 22, 2026
    EDGAR ↗
  • 8-K · Items 1.01, 9.01Material agreementFeb 19, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsFeb 3, 2026
    EDGAR ↗

About AMGEN INC

From SEC EDGAR company records
Industry (SIC 2836)Biological Products, (No Diagnostic Substances)
SectorHealthcare
HeadquartersTHOUSAND OAKS, CA
IncorporatedDE